Target intelligence / Profile preview

Salmonella enterica serovar Enteritidis O-antigen polysaccharide (None commonly used; sometimes referred to as O-Ag or O-antigen, but these are generic terms)

Target
None commonly used; sometimes referred to as O-Ag or O-antigen, but these are generic terms
Molecular classification
Other (specifically, bacterial surface polysaccharide/capsule)
01

Overview

Salmonella enterica serovar Enteritidis O-antigen polysaccharide is a highly variable, surface-exposed carbohydrate polymer that constitutes the O-antigen portion of the lipopolysaccharide (LPS) layer found on the outer membrane of Gram-negative bacteria. Structurally, it is a repeating oligosaccharide chain with a specific serovar-defining composition: in Enteritidis, the backbone consists of mannose, rhamnose, and galactose, plus a distinctive tyvelose sugar that confers serovar specificity (O:9 antigen). Genetic diversity and post-assembly modifications (e.g., glucosylation, acetylation) further alter immunogenicity and serotype features. The O-antigen is a potent virulence factor, enabling resistance to complement-mediated killing, masking other immunogenic surface structures, and aiding environmental persistence and transmission. It is the primary antigenic determinant for Salmonella serotyping and a main candidate for vaccine development, with O-antigen-protein conjugates and GMMA-based systems under investigation for broad, cross-serovar protection. The heterogeneity and immune-modulatory roles of the O-antigen make it both a valuable therapeutic target and a persistent challenge in bacterial vaccine design.

Other names
O-antigenO-polysaccharide (O-PS, OPS)Group IV capsule (historically as “O-antigen capsule” in Salmonella)
02

Mechanism of action

Induction of opsonophagocytic antibodies facilitating immune recognition and clearance of Salmonella Neutralization of polysaccharide antigen via antibody binding Elicitation of cross-protective immunity across serovars

03

Biological functions

Immune evasion/evasion of host immune responseVirulence factorEnvironmental persistenceProtection against complement-mediated lysisModulation of flagellar phase variation
04

Disease associations

Infection (central in Salmonella pathogenesis)Resistance to host immune killingEnvironmental reservoir for transmission
05

Safety considerations

High structural variability of O-antigen between Salmonella strains complicates broad vaccine designPotential for immune escape through capsule/matrix co-expression or phase variationNeed for careful antigenic matching to dominant outbreak strains for effective immunizationRisks of incomplete immunity or serovar replacement in populations
06

Interacting drugs

Conjugate vaccines targeting O-antigen polysaccharide, including experimental candidates using O-antigen-protein conjugates or GMMA (Generalized Modules for Membrane Antigens) technology

1 more in the full profile.

07

Biomarkers

Serological detection of O-antigen structure and its variants for serotyping and immune response monitoringAnti-O-antigen antibodies in patient serum as markers for infection or vaccine response

Beyond the preview

Go deeper on Salmonella enterica serovar Enteritidis O-antigen polysaccharide (None commonly used; sometimes referred to as O-Ag or O-antigen, but these are generic terms).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Enteritidis O-antigen polysaccharide (None commonly used; sometimes referred to as O-Ag or O-antigen, but these are generic terms).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call